Canada Net Change Percentage Gainers & Losers

What Happened?

Shares of cannabis company Tilray Brands fell 16.4% in the after-market session after the company announced it would implement a 1-for-10 reverse stock split. A reverse stock split combines multiple shares into one, which increases the price per share without changing the company's total value. Although management noted the move was intended to make the company more attractive to institutional investors and cut up to $1 million in yearly administrative costs, investors reacted negatively. Such actions can be viewed by the market as an effort to keep a stock's price above an exchange's minimum listing requirements. The significant drop in the stock's price reflected these concerns. Also contributing to the market reaction was the news that the company announced it would implement a 1-for-10 reverse stock split. A reverse stock split combines multiple shares into one, which increases the price per share without changing the company's total value. Although management noted the move was intended to make the company more attractive to institutional investors and cut up to $1 million in yearly administrative costs, investors reacted negatively. Such actions can be viewed by the market as an effort to keep a stock's price above an exchange's minimum listing requirements. The significant drop in the stock's price reflected these concerns.

The shares closed the day at $0.81, down 21.7% from previous close.

The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy Tilray? Access our full analysis report here.

What Is The Market Telling Us

Tilray’s shares are extremely volatile and have had 86 moves greater than 5% over the last year. But moves this big are rare even for Tilray and indicate this news significantly impacted the market’s perception of the business.

The previous big move we wrote about was 14 days ago when the stock dropped 1.8% on the news that the U.S. government passed a spending bill that included provisions to re-criminalize certain hemp-derived THC products. The last-minute provision effectively targeted intoxicating hemp products, such as Delta-8, that had been legalized under the 2018 Farm Bill. This development was viewed as a setback for Canadian cannabis companies like Tilray, which had considered the hemp-derived product segment a key pathway into the lucrative U.S. market. In response to the legislative change, Tilray stated that it expected “no material revenue impact” from the ban.

Tilray is down 43.9% since the beginning of the year, and at $0.82 per share, it is trading 61% below its 52-week high of $2.10 from October 2025.

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Monster and the best and worst performers in the beverages, alcohol, and tobacco industry.

These companies' performance is influenced by brand strength, marketing strategies, and shifts in consumer preferences. Changing consumption patterns are particularly relevant and can be seen in the rise of cannabis, craft beer, and vaping or the steady decline of soda and cigarettes. Companies that spend on innovation to meet consumers where they are with regards to trends can reap huge demand benefits while those who ignore trends can see stagnant volumes. Finally, with the advent of the social media, the cost of starting a brand from scratch is much lower, meaning that new entrants can chip away at the market shares of established players.

The 14 beverages, alcohol, and tobacco stocks we track reported a strong Q3. As a group, revenues beat analysts’ consensus estimates by 2.3% while next quarter’s revenue guidance was in line.

While some beverages, alcohol, and tobacco stocks have fared somewhat better than others, they have collectively declined. On average, share prices are down 1.1% since the latest earnings results.

Monster

Founded in 2002 as a natural soda and juice company, Monster Beverage is a pioneer of the energy drink category, and its Monster Energy brand targets a young, active demographic.

Monster reported revenues of $2.20 billion, up 16.8% year on year. This print exceeded analysts’ expectations by 4.3%. Overall, it was an exceptional quarter for the company with a solid beat of analysts’ EBITDA estimates and a solid beat of analysts’ revenue estimates.

Hilton H. Schlosberg, Chief Executive Officer, said, “The global energy drink category continues to demonstrate solid growth, driven by increasing consumer demand. We again delivered solid financial results in the 2025 third quarter, with record net sales, gross profit dollars, operating income and net income. The results for the quarter reflect the strength of our brands and dedication of our teams around the world. Our Monster Energy Ultra® energy drinks once again contributed significantly to our growth this quarter. Our net sales to customers outside of the United States increased 23.3 percent in the 2025 third quarter to approximately 43 percent of total net sales, up from approximately 40 percent in the 2024 third quarter, and is the highest percentage of net sales to customers outside the United States recorded by the Company to date for a single quarter.

Interestingly, the stock is up 13.8% since reporting and currently trades at $75.47.

Read why we think that Monster is one of the best beverages, alcohol, and tobacco stocks, our full report is free.

Best Q3: Celsius

With its proprietary MetaPlus formula as the basis for key products, Celsius offers energy drinks that feature natural ingredients to help in fitness and weight management.

Celsius reported revenues of $725.1 million, up 173% year on year, outperforming analysts’ expectations by 1.2%. The business had an exceptional quarter with a beat of analysts’ EPS estimates and an impressive beat of analysts’ EBITDA estimates.

Celsius pulled off the fastest revenue growth among its peers. Although it had a fine quarter compared its peers, the market seems unhappy with the results as the stock is down 32.8% since reporting. It currently trades at $40.78.

Is now the time to buy Celsius? Access our full analysis of the earnings results here, it’s free for active Edge members.

Weakest Q3: Altria

Best known for its Marlboro brand of cigarettes, Altria offers tobacco and nicotine products.

Altria reported revenues of $5.25 billion, down 1.7% year on year, falling short of analysts’ expectations by 1.3%. It was a slower quarter as it posted a significant miss of analysts’ gross margin estimates and a slight miss of analysts’ revenue estimates.

As expected, the stock is down 5.2% since the results and currently trades at $58.73.

Read our full analysis of Altria’s results here.

Coca-Cola

A pioneer and behemoth in carbonated soft drinks, Coca-Cola is a storied beverage company best known for its flagship soda.

Coca-Cola reported revenues of $12.41 billion, up 3.9% year on year. This result was in line with analysts’ expectations. It was a satisfactory quarter as it also put up an impressive beat of analysts’ organic revenue estimates.

The stock is up 6.3% since reporting and currently trades at $72.90.

Read our full, actionable report on Coca-Cola here, it’s free for active Edge members.

Tilray

Founded in 2013, Tilray Brands engages in cannabis research, cultivation, and distribution, offering a range of medical and recreational cannabis products, hemp-based foods, and alcoholic beverages.

Tilray reported revenues of $209.5 million, up 4.7% year on year. This number surpassed analysts’ expectations by 2.7%. It was a strong quarter as it also recorded an impressive beat of analysts’ adjusted operating income estimates and a solid beat of analysts’ revenue estimates.

The stock is down 49.7% since reporting and currently trades at $0.87.

Read our full, actionable report on Tilray here, it’s free for active Edge members.